Neurology Medical News about Dystonia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cervical dystonia
Future Neurology, 10/12/09

Alpers JP et al. – Cervical dystonia is a common disorder with significant associated morbidity. Although limited benefit can be derived from oral pharmacologic agents, the advent of botulinum neurotoxin (BoNT) injection has provided a valuable tool in the treatment of this disorder. In order to provide effective treatment, the physician must have an intimate knowledge of the anatomy and function of the neck musculature. Novel BoNT formulations, even of the same serotype, are not equivalent and thus require careful dose titration. Formulation improvements may result in reduced immunoresistance. In patients labeled as treatment resistant to BoNT, careful electromyographic reassessment of select muscles for injection will frequently result in improved clinical benefit.

<< Previous
Adherence to Acute Migraine Medication: What Does It Mean, Why...

Next >>
HIT-6 and MIDAS as Measures of Headache Disability in a Headache...

Upper Limbs Function After Intrathecal Baclofen Therapy in Children With Secondary Dystonia
Journal of Pediatric Orthopaedics, 10/01/09 Relevance Score: 92%

Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment
Journal of Paediatrics and Child Health, 10/28/09 Relevance Score: 90%

Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia
Movement Disorders, 11/17/09 Relevance Score: 88%

Paramedical treatment in primary dystonia: A systematic review
Movement Disorders, 10/30/09 Relevance Score: 88%

A Case of Secondary Dystonia Responding to Levodopa
Journal of Child Neurology, 10/27/09 Relevance Score: 88%